Harbor MedTech, Inc., announced today FDA clearance for its first product, Architect™, which it describes as an advanced collagen matrix for treatment of skin wounds. In the press release, Harbor MedTech President and Founder Jerry Mezger states that:
[T]he FDA has cleared Architect™ for treating a wide variety of serious skin wounds, including diabetic foot ulcers, venous leg ulcer, pressure ulcers, and many other trauma or surgery related skin wounds[.]
According to the press release, shipments of the device will begin in April. Harbor MedTech is a medical device company based in Irvine, California. Harbor MedTech’s press release is available here.